In the current era of immunotherapy, it is understood that these controversial results are largely due to the dual roles of IFNγ; it is also able to promote tumor development and progression, particularly by upregulating aggression and immune checkpoint molecules, such as the PD-1/PD-L1 axis3. The gene discussed is CD274; the disease is neoplasm.